Abstract:A pillararene‐baded supramolecular vesicles are constructed for Alzheimer disease treatment, which can load resveratrol, chelate zinc ion and inhibit Aβ fibrillation. The resveratrol is released in zinc ion environment to reprogram microglial phenotype and alleviate neuroinflammation, and thus eventually ameliorate cognitive impairment in AD mouse models. Zn2+‐induced β‐amyloid protein (Aβ) aggregation and microglia activation are the predominant contributors in Alzheimer's disease (AD). Regulating intracephalic excessive Zn2+ is a promising therapeutic strategy for AD treatment. However, only inhibition of Zn2+ is hardly to repair continuous damages caused by activated microglia. Herein, an intelligent resveratrol‐loaded supramolecular vesicles (RES‐loaded vesicles) with zinc ion chelation function and responsive release capability are constructed to alleviate Aβ fibrillation, oxidative stress, and microglial dysfunction. The resveratrol encapsulation efficiency and drug loading efficiency are calculated to be 49.67% and 7.87%, respectively. In vitro studies demonstrate that the RES‐loaded vesicles can modulate Zn2+‐dependent Aβ aggregation. More importantly, the cargoes will be released in zinc environment and further reprograms microglia from proinflammatory M1 phenotype toward anti‐inflammatory M2 phenotype, which prevents spontaneous neuroinflammation and alleviates cytotoxicity of cultured cells from 29% to 12%. With the stereotactic or intranasal administration, RES‐loaded vesicles can overcome the blood brain barrier, alleviate neuronal apoptosis, neuroinflammation, and ultimately ameliorate cognitive impairment in two AD mouse models. This work provides a new sight for taking advantage of Zn2+ to treat CNS disorders.

Targeting Zincosomes to Unveil Lysosomal Zinc ion Dynamics and Their Role in Exacerbating Alzheimer's Pathology

Targeted imaging of lysosomal zinc ions with a tetrahedral DNA framework fluorescent reporter

Zinc Transporters in Alzheimer’s Disease

In Vivo Target Bio-Imaging of Alzheimer's Disease by Fluorescent Zinc Oxide Nanoclusters.

Multifunctional roles of zinc in Alzheimer’s disease

Disruption of Brain Zinc Homeostasis Promotes the Pathophysiological Progress of Alzheimer's Disease.

Tracking Mitochondrial Cu(I) Fluctuations Through a Ratiometric Fluorescent Probe in AD Model Cells: Towards Understanding How AβOs Induce Mitochondrial Cu(I) Dyshomeostasis

In Vivo Rapid Fluorescence Imaging of Alzheimer’s Disease Through Accurate Target Bio-Marking of Zinc Gluconate

Multifunctional Supramolecular Vesicles as Zn<sup>2+</sup>‐Triggered Microglial Modulator Alleviates Alzheimer's Disease

Brain Zinc Metabolism and Alzheimer's Disease

Alzheimer's disease, beta-amyloid protein and zinc.

Zinc exacerbates tau-induced Alzheimer-like pathology in C57BL/6J mice

Zinc and its effects on oxidative stress in Alzheimer’s disease

Multifunctional Supramolecular Vesicles as Zn2+‐Triggered Microglial Modulator Alleviates Alzheimer's Disease

Revealing the Amyloid Β-Protein with Zinc Finger Protein of Micronucleus During Alzheimer's Disease Progress by a Quaternary Ammonium Terpyridine Probe.

MORPHOLOGICAL EVIDENCE OF ZINC IONS INVOLVED IN β-AMYLOID PLAQUE FORMATION IN ALZHEIMER'S DISEASE

In Vivo Biosynthesized Zinc and Iron Oxide Nanoclusters for High Spatiotemporal Dual-Modality Bioimaging of Alzheimer's Disease.

Molecular mechanism of zinc neurotoxicity in Alzheimer’s disease

Sensitive Imaging and Effective Capture of Cu2+: Towards Highly Efficient Theranostics of Alzheimer's Disease

Ratiometric Fluorescence Imaging of Lysosomal Zn2+ Release under Oxidative Stress in Neural Stem Cells.

Visualization of cysteine in AD mouse with a high-quantum yield NIR fluorescent probe